Cargando…

Resolution of Keratoacanthoma Type Squamous Cell Carcinoma Following Intralesional Therapy With Methotrexate

Keratoacanthoma is considered a variant of squamous cell carcinoma prone to spontaneous involution, but it may also rapidly grow and invade surrounding tissues. Herein, we report a case of keratoacanthoma-type squamous cell carcinoma that resolved after intralesional therapy with methotrexate.

Detalles Bibliográficos
Autores principales: Sisti, Andrea, Huayllani, Maria T, Boczar, Daniel, Fosko, Scott, Forte, Antonio J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292709/
https://www.ncbi.nlm.nih.gov/pubmed/32542147
http://dx.doi.org/10.7759/cureus.8092
_version_ 1783546163580895232
author Sisti, Andrea
Huayllani, Maria T
Boczar, Daniel
Fosko, Scott
Forte, Antonio J
author_facet Sisti, Andrea
Huayllani, Maria T
Boczar, Daniel
Fosko, Scott
Forte, Antonio J
author_sort Sisti, Andrea
collection PubMed
description Keratoacanthoma is considered a variant of squamous cell carcinoma prone to spontaneous involution, but it may also rapidly grow and invade surrounding tissues. Herein, we report a case of keratoacanthoma-type squamous cell carcinoma that resolved after intralesional therapy with methotrexate.
format Online
Article
Text
id pubmed-7292709
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-72927092020-06-14 Resolution of Keratoacanthoma Type Squamous Cell Carcinoma Following Intralesional Therapy With Methotrexate Sisti, Andrea Huayllani, Maria T Boczar, Daniel Fosko, Scott Forte, Antonio J Cureus Dermatology Keratoacanthoma is considered a variant of squamous cell carcinoma prone to spontaneous involution, but it may also rapidly grow and invade surrounding tissues. Herein, we report a case of keratoacanthoma-type squamous cell carcinoma that resolved after intralesional therapy with methotrexate. Cureus 2020-05-13 /pmc/articles/PMC7292709/ /pubmed/32542147 http://dx.doi.org/10.7759/cureus.8092 Text en Copyright © 2020, Sisti et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Sisti, Andrea
Huayllani, Maria T
Boczar, Daniel
Fosko, Scott
Forte, Antonio J
Resolution of Keratoacanthoma Type Squamous Cell Carcinoma Following Intralesional Therapy With Methotrexate
title Resolution of Keratoacanthoma Type Squamous Cell Carcinoma Following Intralesional Therapy With Methotrexate
title_full Resolution of Keratoacanthoma Type Squamous Cell Carcinoma Following Intralesional Therapy With Methotrexate
title_fullStr Resolution of Keratoacanthoma Type Squamous Cell Carcinoma Following Intralesional Therapy With Methotrexate
title_full_unstemmed Resolution of Keratoacanthoma Type Squamous Cell Carcinoma Following Intralesional Therapy With Methotrexate
title_short Resolution of Keratoacanthoma Type Squamous Cell Carcinoma Following Intralesional Therapy With Methotrexate
title_sort resolution of keratoacanthoma type squamous cell carcinoma following intralesional therapy with methotrexate
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292709/
https://www.ncbi.nlm.nih.gov/pubmed/32542147
http://dx.doi.org/10.7759/cureus.8092
work_keys_str_mv AT sistiandrea resolutionofkeratoacanthomatypesquamouscellcarcinomafollowingintralesionaltherapywithmethotrexate
AT huayllanimariat resolutionofkeratoacanthomatypesquamouscellcarcinomafollowingintralesionaltherapywithmethotrexate
AT boczardaniel resolutionofkeratoacanthomatypesquamouscellcarcinomafollowingintralesionaltherapywithmethotrexate
AT foskoscott resolutionofkeratoacanthomatypesquamouscellcarcinomafollowingintralesionaltherapywithmethotrexate
AT forteantonioj resolutionofkeratoacanthomatypesquamouscellcarcinomafollowingintralesionaltherapywithmethotrexate